Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06467604 · ClinicalTrials.gov registry record
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
A clinical trial of Obesity, sponsored by University of California, Davis.
- Active
- Registry status
- 7
- Enrollment target
- 1
- Study location
NCT06467604 is a study of Obesity that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 7 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06467604, a study of Obesity, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to assess the impact of GLP-1 receptor agonists, semaglutide and tirzepatide, on food cravings and diet quality in individuals with overweight or obesity. Over 24 weeks, up to 150 adult participants will be monitored using questionnaires and dietary records at 0, 12, and 24 weeks to measure changes in diet quality, disordered eating, food cravings, and hunger. This research, conducted with Seen Medical Group at Knownwell Health Clinic, seeks to fill the gap in literature on the dietary quality effects of GLP-1RAs.
Conditions Studied
Interventions
- BEHAVIORAL Surveys
- OTHER Indirect Calorimetry
- OTHER Body composition
- OTHER Anthropometrics
Study Locations (1)
Massachusetts
- Knownwell - Needham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2026-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06467604
The ClinicalTrials.gov registry entry for NCT06467604 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 4 interventions - of which Surveys is the first listed.
NCT06467604 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06467604 about?
NCT06467604 is a clinical study titled "CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users". This study aims to assess the impact of GLP-1 receptor agonists, semaglutide and tirzepatide, on food cravings and diet quality in individuals with overweight or obesity. Over 24 weeks, up to 150 adult participants will be monitored using questionnaires and dietary records at 0, 12, and 24 weeks to ...
What is the current status of trial NCT06467604?
This trial is currently active not recruiting. The enrollment target is 7 participants. The study started on 2024-11-01. Estimated completion is 2026-04-01.
What conditions does trial NCT06467604 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT06467604?
The interventions under investigation include: Surveys (BEHAVIORAL), Indirect Calorimetry (OTHER), Body composition (OTHER), Anthropometrics (OTHER).
Who is sponsoring clinical trial NCT06467604?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06467604 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.